Hear them roar: Forbes.com ranks Rite Aid’s Sammons among most powerful women
NEW YORK Forbes.com last week published its list of the “World’s 100 Most Powerful Women.” No. 3 on that list: Indra Nooyi, CEO of PepsiCo, who falls behind the chancellor of Germany and the Federal Deposit Insurance Corp. chairman.
“In assembling the list, Forbes looked for women who run countries, big companies or influential nonprofits,” wrote Francesca Donner, online edtor of ForbesWoman. “Their rankings are a combination of two scores — visibility, by press mentions, and the size of the organization or country these women lead.”
Mary Sammons, chairman and CEO of Rite Aid, ranks as the No. 1 retailer on the list and No. 21 overall. A considerable mention, as Sammons places higher on the list than either First Lady Michelle Obama or Oprah (ranked Nos. 40 and 41, respectively).
Following are the U.S. women and their respective place on the Forbes.com list who either work in or have influence on the retail pharmacy industry:
3. Indra Nooyi, chairman and CEO, PepsiCo6. Irene Rosenfeld, chairman and CEO, Kraft Foods8. Angela Braly, president and CEO, WellPoint21. Mary Sammons, chairman and CEO, Rite Aid29. Brenda Barnes, chairman and CEO, Sara Lee Corp.30. Risa Lavizzo-Mourey, president and CEO, The Robert Wood Johnson Foundation39. Susan Chambers, EVP of the Global People Division, Wal-Mart Stores54. Gail Boudreaux, president, UnitedHealthcare57. Kathleen Sebelius, Secretary of the Department of Health & Human Services66. Sherilyn McCoy, worldwide chairman, Pharmaceuticals Group, Johnson & Johnson74. Deirdre Connelly, president, North American Pharmaceuticals, GlaxoSmithkline78. Colleen Goggins, worldwide chairman, Consumer Group, Johnson & Johnson81. Amy Schulman, SVP and general counsel, Pfizer84. Melanie Healey, group president, Feminine & Health Care, Procter & Gamble
Winn-Dixie reports Q4, fiscal-year results
JACKSONVILLE, Fla. Winn-Dixie closed out the year on a strong note Monday, reporting $7.4 billion in net sales, up 1.2%, for the fiscal year ended June 24, with identical-store sales from continuing operations up 1.2% compared with the prior fiscal year.
During a conference call Tuesday morning, Winn-Dixie chairman, president and CEO Peter Lynch told analysts that the chain’s remodel program, scheduled to be completed across the chain’s entire store base by fiscal year 2013, will be a key driver in the grocer’s success going forward, as will pharmacy.
“Script counts are up,” noted Lynch. “As far as pharmacy plays into our promotional activity, as I have said in the past, pharmacy is a key component to our strategy going forward,” he said. Primarily because pharmacy customers, no matter which channel from which they pick up their prescriptions, are sticky customers. “So we are always trying to make sure that we keep those customers and reach out to them for more business,” Lynch said.
And right now, that means better customer service than the pharmacy down the street. “We’ve done a lot of work in making sure that our pharmacists are really out there taking care of the customer,” he said. “The customer really needs that approach regarding pharmacy and I think we’re doing a much, much better job at it here at Winn-Dixie today.”
Lynch updated analysts around Winn-Dixie’s store remodeling program, which Winn-Dixie is tackling on a market-by-market basis. The grocer’s hometown market of Jacksonville, Fla., home to 51 stores across north Florida and south Georgia, was completed in mid-July. “We are currently on track to remodel half of our stores by the end of fiscal year 2010 and to complete substantially all of our stores by 2013,” Lynch said.
At the end of fiscal 2009, the company had completed 170 store remodels, 73 of which were still within their first year of operation. Of the 73 first-year store remodels, 47 are considered by the company to be offensive remodels. For fiscal 2009, those 47 stores had a 10.3% weighted average sales increase compared to the same period in the prior fiscal year, excluding the grand re-opening phase. The sales increase resulted from increases in transaction count and basket size of 5.6% and 4.5%, respectively.
Diplomat Specialty Pharmacy, CareSource announce partnership to treat CKD
SWARTZ CREEK, Mich. A specialty pharmacy in the Midwest will partner with another company to help treat people with chronic kidney disease.
Diplomat Specialty Pharmacy announced this week that its Diplomat Health Services Division would partner with Ohio-based CareSource in an effort to slow the progression of kidney disease, improve clinical outcomes and reduce costs associated with it.
“Early recognition and intervention are essential to slowing disease progression and improving outcomes,” CareSource chief medical officer Craig Thiele said in a statement. “Collaboration and creating a communication continuum, as well as enhancing patient and physician education, goal setting and tracking outcomes ensure success for all stakeholders.”
According to the National Kidney Foundation, chronic kidney disease affects 26 million Americans, while millions more are at increased risk. It’s one of the many complications of hypertension, but it can also cause hypertension, and it often affects people with diabetes.
Diplomat said that in pilot studies, its CKD Navigator disease management program showed significant medication and medical cost savings while improving results among patients by incorporating medication therapy management, medication adherence tools and lifestyle management techniques.
“We have demonstrated the savings,” Diplomat VP clinical services Ron Alexander said in a statement. “Now, with the CareSource project, we plan to not only show good financial metrics, but also incorporate lifestyle information to gauge the program’s health effects.”